Cite
MLA Citation
Mark A. Espeland et al.. “Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase‐4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes: A subgroup analysis of the randomized CAROLINA trial.” Diabetes, obesity & metabolism, vol. 23, no. 2, 2021, pp. 569–580. http://access.bl.uk/ark:/81055/vdc_100118925386.0x00001e